You are here: Industry Insights > Agilent

News List

Agilent Tech to acquire Lasergen for $105M biospectrumasia
April 04, 2018
Lasergen and Agilent have been collaborating on building a next-generation sequencing workflow for clinical applications.
Agilent creates new colour to detect cancer biospectrumasia
March 19, 2018
The excellent staining characteristics of the new chromogen make it particularly useful for assessment of skin and lung tissue
Agilent won two 2018 Scientists’ Choice Awards biospectrumasia
March 14, 2018
Awards for Best New Spectroscopy and Best New Separation Products
Agilent Technologies to acquire Advanced Analytical Tech biospectrumasia
March 08, 2018
This acquisition will enhance Agilent’s existing expertise and technology, while giving customers a more comprehensive set of solutions.
Agilent Technologies announces revolutionary Triple Quadrupole Mass Spectrometer biospectrumasia
August 02, 2017
Agilent Technologies announces revolutionary Triple Quadrupole Mass Spectrometer Ultivo is optimized to address the food and environmental routine testing segments employing triple quad LC/MS systems for quantitative analyses.
Agilent Technologies acquires raman spectroscopy innovator, Cobalt Light Systems europeanpharmaceuticalreview
July 12, 2017
Cobalt’s portfolio of solutions accelerates entry into high-growth Raman spectroscopy market and expands Agilent’s value proposition for pharmaceutical and biopharma customers…
Innovation with a purpose at Agilent europeanpharmaceuticalreview
July 12, 2017
David Edwards explains how Agilent spectroscopy systems combine core qualities of robustness and reliability with a spirit of innovation.
Agilent Technologies announces the launch of Ultivo Triple quad mass spectrometer biospectrumasia
June 23, 2017
The Agilent Ultivo solution is set to be the most innovative, cost- efficient and smallest LC/MS solution offered in the industry.
Agilent Technologies announces expanded use for PD-L1 IHC 28-8 pharmDx diagnostic in Europe biospectrumasia
May 16, 2017
Approved for use in Europe to identify head and neck Cancer patients most likely to benefit from Opdivo (nivolumab) Therapy
Agilent Technologies enhances exome sequencing for clinical research biospectrumasia
March 23, 2017
New target enrichment product delivers deep coverage of disease relevant content

Previous page 1 2 3 Next page